Answers are grounded in this paper and cite their sources.
Considerable differences in the probability of reporting unreliable Hb A(1c) results between different NGSP (formerly the National Glycohemoglobin Standardization Program)-certified platforms were observed. At a 6% TE(a), our study indicates all but the Capillarys 2 Flex Piercing requires that the maximum affordable QC be run. Risk estimates for individual laboratories' Hb A(1c) methods can be used to assess QC practices and residual risk of an unreliable Hb A(1c) result.
No takes yet. Share an insight, caveat, or question.
Woodworth et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: